Driving Greater Efficiency Through Modular Trial Design

Traditional clinical trial models, dependent on centralized sites and manual processes, are struggling to meet the demands of modern drug development, especially as patient expectations rise and protocols grow more complex. These legacy systems often face critical challenges such as poor patient recruitment, high dropout rates, operational inefficiencies, and underrepresentation of diverse populations. In response, the industry is shifting toward more flexible, modular, and patient-centric approaches to trial execution.

Emerging models — such as decentralized and hybrid trials — integrate innovative technologies like remote monitoring, eConsent platforms, and home trial support to reduce patient burden and improve data quality. Modular trial delivery, in particular, allows sponsors to scale services, engage broader populations, and better align with global site capabilities. MRN exemplifies this model, offering a suite of services that includes a global site network, in-home trial capabilities, and comprehensive site and patient support.

By embedding these flexible tools into the early planning stages of clinical development, sponsors can accelerate timelines, reduce costs, and improve trial outcomes. MRN’s approach fosters operational clarity and inclusivity while maintaining high retention rates and regulatory compliance. This evolution in trial design marks a critical step toward faster, more equitable access to innovative therapies worldwide.